High communication standards key to the success of the UK biotech industry

摘要

Public or private censure, and suspension or expulsion from the Bioindustry Association, are the sanctions that UK biotech companies could face if they persistently and seriously breach the association's just-released best practice guidance on financial and corporate communications.With such communications, the UK biotech sector "cannot afford mistakes or poor practice, and the destabilisation that would ensue", says the chief executive of the BIA Aisling Burnand.